The finding of significantly higher peripheral S100B concentrations in patients with ADHD in relation to non-related controls in our study is in line with the hypothesis of global neuroinflammation leading to the dopaminergic disruption observed in this disorder. The gene discussed is S100B; the disease is attention deficit-hyperactivity disorder.